Annual Congress Vienna 2009

Saturday, 12.09.2009
Sunday, 13.09.2009
Monday, 14.09.2009
Tuesday, 15.09.2009
Wednesday, 16.09.2009

Citations should be made in the following way: Authors. Title. Eur Respir J 2009; 34: Suppl. 53, abstract number.

Material from 2009:

4047 Abstracts
652 Slide presentations
300 Webcasts
93 Handouts
2150 e-posters
300 Multimedia files

Material from 2009: Show

Impact of biomarkers in the management of community-acquired pneumonia

Oral Presentation
Chairs: D. Stolz (Arlesheim, Switzerland), M. Woodhead (Manchester, United Kingdom)

Download all media

Pro-atrial natriuretic peptide and pro-vasopressin to predict short- and long-term survival in community-acquired pneumonia S. Krueger, S. Ewig, J. Kunde, R. Marre, N. Suttorp, T. Welte (Aachen, Bochum, Hennigsdorf, Ulm, Berlin, Hannover, Germany)
Pro-vasopressin (copeptin) in patients with community-acquired pneumonia – influence of antibiotic pre-treatment; results from the German competence network CAPNETZ S. Krueger, S. Ewig, J. Kunde, R. Marre, N. Suttorp, T. Welte (Aachen, Bochum, Hennigsdorf, Ulm, Berlin, Hannover, Germany)
Determining the prognostic value of procalcitonin in ICU patients who developed hospital acquired pneumonia and comparing with sencitive CRP H. Tanriverdi, M. Tor, L. Kart, R. Alin, F. Atalay, V. Sumbuloglu (Zonguldak, Turkey)
Acute respiratory failure (ARF) and severe sepsis (SS) in community acquired pneumonia (CAP): different outcomes? T. Maraffi, A. Torri, A. M. Brambilla, S. Aliberti, F. Piffer, V. Monzani, V. Rosti, R. Cosentini (Milano, Italy)
Significant decrease in long-term survival for hospitalised patients with community-acquired pneumonia (CAP): results from the community-acquired pneumonia organisation (CAPO) international cohort study J. Bordon, T. Wiemken, M. Luz Paz, S. Memon, M. Del Carmen Venero, P. Cabral, M. Gnoni, P. Peyrani, J. Ramirez (Louisville, Washington, United States Of America)
Comparison of biomarkers and SOFA score prognostic value in ventilator-associated pneumonia R. Seligman, S. Kretzer, V. Martins, L. F. Lima, V. Oliveira, C. Sanvicente, E. Pacheco, J. Sartori, K. Dalla Rosa, L. Restelatto, B. Seligman (Porto Alegre, Brazil)
C-reactive protein (CRP), an early prognostic tool in community acquired pneumonia (CAP) A. Dwarakanath, C. Woods (Hull Royal Infirmary, United Kingdom)
Hyponatremia in community-acquired pneumonia due to increased vasopressin secretion – impact on mortality S. Krueger, J. Kunde, R. Marre, N. Suttorp, T. Welte (Aachen, Henningsdorf, Ulm, Berlin, Hannover, Germany)